These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 226792)
1. Oral contraceptives and plasma protein metabolism. Briggs MH; Briggs M J Steroid Biochem; 1979 Jul; 11(1B):425-8. PubMed ID: 226792 [TBL] [Abstract][Full Text] [Related]
2. Comparison of metabolic and clinical effects of four oral contraceptive formulations and a contraceptive vaginal ring. Roy S; Mishell DR; Gray G; Dozono-Takano R; Brenner PF; Eide I; de Quattro V; Shaw ST Am J Obstet Gynecol; 1980 Apr; 136(7):920-31. PubMed ID: 6767404 [TBL] [Abstract][Full Text] [Related]
3. Comparative studies of the ethynyl estrogens used in oral contraceptives. VII. Effects with and without progestational agents on ultracentrifugally fractionated plasma lipoproteins in humans, baboons, and beagles. Goldzieher JW; Chenault CB; de la Peña A; Dozier TS; Kraemer DC Fertil Steril; 1978 Nov; 30(5):522-33. PubMed ID: 214353 [TBL] [Abstract][Full Text] [Related]
4. Changes in coagulation and anticoagulation in women taking low-dose triphasic oral contraceptives: a controlled comparative 12-month clinical trial. Notelovitz M; Kitchens CS; Khan FY Am J Obstet Gynecol; 1992 Nov; 167(5):1255-61. PubMed ID: 1442974 [TBL] [Abstract][Full Text] [Related]
5. The effect of oestrogen dose and progestogen type on haemostatic changes in women taking low dose oral contraceptives. Norris LA; Bonnar J Br J Obstet Gynaecol; 1996 Mar; 103(3):261-7. PubMed ID: 8630312 [TBL] [Abstract][Full Text] [Related]
6. [Influence of progestins on adverse effects of oral contraceptives]. Wynn V Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):425-30. PubMed ID: 12280210 [TBL] [Abstract][Full Text] [Related]
7. Comparative studies of the ethynyl estrogens used in oral contraceptives. III. Effect on plasma gonadotropins. Goldzieher JW; de la Peña A; Chenault CB; Cervantes A Am J Obstet Gynecol; 1975 Jul; 122(5):625-36. PubMed ID: 1146928 [TBL] [Abstract][Full Text] [Related]
8. Anti-estrogens and plasma proteins. II. Contraceptive drugs and gestagens. Barbosa J; Seal US; Doe RP J Clin Endocrinol Metab; 1973 Apr; 36(4):706-14. PubMed ID: 4119677 [TBL] [Abstract][Full Text] [Related]
9. A comparative metabolic study of two low-estrogen-dose oral contraceptives containing desogestrel or gestodene progestins. Crook D; Godsland IF; Worthington M; Felton CV; Proudler AJ; Stevenson JC Am J Obstet Gynecol; 1993 Nov; 169(5):1183-9. PubMed ID: 8238183 [TBL] [Abstract][Full Text] [Related]
10. Hemostasis profile and lipid metabolism with long-interval use of a desogestrel-containing oral contraceptive. Cachrimanidou AC; Hellberg D; Nilsson S; von Schoulz B; Crona N; Siegbahn A Contraception; 1994 Aug; 50(2):153-65. PubMed ID: 7956214 [TBL] [Abstract][Full Text] [Related]
11. Oral contraceptive and postmenopausal estrogen effects on lipoprotein triglyceride and cholesterol in an adult female population: relationships to estrogen and progestin potency. Knopp RH; Walden CE; Wahl PW; Hoover JJ; Warnick GR; Albers JJ; Ogilvie JT; Hazzard WR J Clin Endocrinol Metab; 1981 Dec; 53(6):1123-32. PubMed ID: 7298796 [TBL] [Abstract][Full Text] [Related]
12. Control of fertility with oral medication. Diddle AW; Watts GF; Gardner WH; Williamson PJ West J Surg Obstet Gynecol; 1964; 72():222-9. PubMed ID: 12305556 [TBL] [Abstract][Full Text] [Related]
13. Changes in blood levels of proteinase inhibitors, pregnancy zone protein, steroid carriers and complement factors induced by oral contraceptives. Nielsen CH; Poulsen HK; Teisner B; Thorsen P; Hau J; Westergaard JG Eur J Obstet Gynecol Reprod Biol; 1993 Sep; 51(1):63-71. PubMed ID: 7506680 [TBL] [Abstract][Full Text] [Related]
14. Effect of estrogen/progestin potency on lipid/lipoprotein cholesterol. Wahl P; Walden C; Knopp R; Hoover J; Wallace R; Heiss G; Rifkind B N Engl J Med; 1983 Apr; 308(15):862-7. PubMed ID: 6572785 [TBL] [Abstract][Full Text] [Related]
15. A prospective controlled study of the effect on blood pressure of contraceptive preparations containing different types and dosages of progestogen. Wilson ES; Cruickshank J; McMaster M; Weir RJ Br J Obstet Gynaecol; 1984 Dec; 91(12):1254-60. PubMed ID: 6440589 [TBL] [Abstract][Full Text] [Related]
16. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids. Kakis G; Powell M; Marshall A; Woutersz TB; Steiner G Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162 [TBL] [Abstract][Full Text] [Related]
17. Serum lipids and lipoproteins during treatment with oral contraceptives containing natural and synthetic oestrogens. A controlled double-blind investigation. Bostofte E; Hemmingsen L; Møller KJ; Serup J; Weber T Acta Endocrinol (Copenh); 1978 Apr; 87(4):855-64. PubMed ID: 347855 [TBL] [Abstract][Full Text] [Related]
18. Studies on plasma coagulation and fibrinolysis during oral contraception of various types with special reference to cold activation of factor VII. Gjonnaess H; Fagerhol MK Scand J Haematol; 1974; 12(3):232-40. PubMed ID: 4831827 [TBL] [Abstract][Full Text] [Related]
19. The metabolic impact of oral contraceptives. Krauss RM; Burkman RT Am J Obstet Gynecol; 1992 Oct; 167(4 Pt 2):1177-84. PubMed ID: 1415443 [TBL] [Abstract][Full Text] [Related]
20. Effects on sex hormone binding globulin of different oral contraceptives containing norethisterone and lynestrenol. Odlind V; Weiner E; Victor A; Johansson ED Br J Obstet Gynaecol; 1980 May; 87(5):416-21. PubMed ID: 6155933 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]